» Articles » PMID: 37063278

The Role of MicroRNAs in Depression

Overview
Journal Front Pharmacol
Date 2023 Apr 17
PMID 37063278
Authors
Affiliations
Soon will be listed here.
Abstract

Major depressive disorder (MDD) is a psychiatric disorder with increasing prevalence worldwide. It is a leading cause of disability and suicide, severely affecting physical and mental health. However, the study of depression remains at an exploratory stage in terms of diagnostics and treatment due to the complexity of its pathogenesis. MicroRNAs are endogenous short-stranded non-coding RNAs capable of binding to the 3'untranslated region of mRNAs. Because of their ability to repress translation process of genes and are found at high levels in brain tissues, investigation of their role in depression has gradually increased recently. This article summarizes recent research progress on the relationship between microRNAs and depression. The microRNAs play a regulatory role in the pathophysiology of depression, involving dysregulation of monoamines, abnormalities in neuroplasticity and neurogenesis, hyperactivity of the HPA axis, and dysregulation of inflammatory responses. These microRNAs might provide new clue for the diagnosis and treatment of MDD, and the development of antidepressant drugs.

Citing Articles

The underlying mechanisms of the association of bone health with depression - an experimental study.

Houtenbos S, He Y, Cazzanelli P, Soultoukis G, Wuertz-Kozak K, Schulz T Mol Biol Rep. 2025; 52(1):163.

PMID: 39869252 PMC: 11772516. DOI: 10.1007/s11033-025-10230-x.


MicroRNA signatures in neuroplasticity, neuroinflammation and neurotransmission in association with depression.

Choudhary A, Kumar A, Jindal M, Rhuthuparna M, Munshi A J Physiol Biochem. 2024; .

PMID: 39695016 DOI: 10.1007/s13105-024-01065-4.


MicroRNA Expression Profile Is Altered by Short-Term and Chronic Lithium Treatment in a Rat Model of Depression.

Kachel M, Dola A, Kubiak M, Majewska W, Nowakowska J, Langwinski W J Mol Neurosci. 2024; 74(4):116.

PMID: 39674983 DOI: 10.1007/s12031-024-02298-0.


A Cross-Sectional Trait Versus State Biomarker Analysis of Inflammatory Cytokines and miRNAs in Patients with Major Depressive Disorder.

Rockson C, Girish C, Natarajan H, Menon V Indian J Psychol Med. 2024; 47(1):57-64.

PMID: 39564330 PMC: 11572534. DOI: 10.1177/02537176241279110.


Fructus Arctii Mitigates Depressive Disorder via the Let-7e-Modulated Toll-Like Receptor (TLR) Signaling Pathway.

Zhang W, Zhou Q Brain Behav. 2024; 14(11):e70132.

PMID: 39538967 PMC: 11560858. DOI: 10.1002/brb3.70132.


References
1.
Petra A, Panagiotidou S, Hatziagelaki E, Stewart J, Conti P, Theoharides T . Gut-Microbiota-Brain Axis and Its Effect on Neuropsychiatric Disorders With Suspected Immune Dysregulation. Clin Ther. 2015; 37(5):984-95. PMC: 4458706. DOI: 10.1016/j.clinthera.2015.04.002. View

2.
Kiecolt-Glaser J, Derry H, Fagundes C . Inflammation: depression fans the flames and feasts on the heat. Am J Psychiatry. 2015; 172(11):1075-91. PMC: 6511978. DOI: 10.1176/appi.ajp.2015.15020152. View

3.
Segal D, Kuczenski R, Mandell A . Theoretical implications of drug-induced adaptive regulation for a biogenic amine hypothesis of affective disorder. Biol Psychiatry. 1974; 9(2):147-59. View

4.
Huang P, Wei S, Luo M, Tang Z, Lin Q, Wang X . MiR-139-5p has an antidepressant-like effect by targeting phosphodiesterase 4D to activate the cAMP/PKA/CREB signaling pathway. Ann Transl Med. 2021; 9(20):1594. PMC: 8576692. DOI: 10.21037/atm-21-5149. View

5.
Malhi G, Mann J . Depression. Lancet. 2018; 392(10161):2299-2312. DOI: 10.1016/S0140-6736(18)31948-2. View